» Articles » PMID: 39442672

Cardiac Diffusion-weighted and Tensor Imaging: A Consensus Statement from the Special Interest Group of the Society for Cardiovascular Magnetic Resonance

Abstract

Thanks to recent developments in cardiovascular magnetic resonance (CMR), cardiac diffusion-weighted magnetic resonance is fast emerging in a range of clinical applications. Cardiac diffusion-weighted imaging (cDWI) and diffusion tensor imaging (cDTI) now enable investigators and clinicians to assess and quantify the tridimensional microstructure of the heart. Free-contrast DWI is uniquely sensitized to the presence and displacement of water molecules within the myocardial tissue, including the intracellular, extracellular, and intravascular spaces. CMR can determine changes in microstructure by quantifying: a) mean diffusivity (MD)-measuring the magnitude of diffusion; b) fractional anisotropy (FA)-specifying the directionality of diffusion; c) helix angle (HA) and transverse angle (TA)-indicating the orientation of the cardiomyocytes; d) absolute sheetlet angle (E2A) and E2A mobility-measuring the alignment and systolic-diastolic mobility of the sheetlets, respectively. This document provides recommendations for both clinical and research cDWI and cDTI, based on published evidence when available and expert consensus when not. It introduces the cardiac microstructure focusing on the cardiomyocytes and their role in cardiac physiology and pathophysiology. It highlights methods, observations, and recommendations in terminology, acquisition schemes, postprocessing pipelines, data analysis, and interpretation of the different biomarkers. Despite the ongoing challenges discussed in the document and the need for ongoing technical improvements, it is clear that cDTI is indeed feasible, can be accurately and reproducibly performed and, most importantly, can provide unique insights into myocardial pathophysiology.

Citing Articles

Cardiac Magnetic Resonance Imaging in Diagnostics and Cardiovascular Risk Assessment.

Matusik P, Mikrut K, Bryll A, Popiela T, Matusik P Diagnostics (Basel). 2025; 15(2).

PMID: 39857062 PMC: 11764230. DOI: 10.3390/diagnostics15020178.


Circulating microRNA as promising biomarkers in hypertrophic cardiomyopathy: can advanced cardiac magnetic resonance unlock new insights in research?.

Chumakova O, Mershina E Exp Biol Med (Maywood). 2025; 249():10334.

PMID: 39744621 PMC: 11688189. DOI: 10.3389/ebm.2024.10334.

References
1.
Phipps K, van de Boomen M, Eder R, Michelhaugh S, Spahillari A, Kim J . Accelerated in Vivo Cardiac Diffusion-Tensor MRI Using Residual Deep Learning-based Denoising in Participants with Obesity. Radiol Cardiothorac Imaging. 2021; 3(3):e200580. PMC: 8259662. DOI: 10.1148/ryct.2021200580. View

2.
Klein V, Coll-Font J, Vendramini L, Straney D, Davids M, Ferris N . Measurement of magnetostimulation thresholds in the porcine heart. Magn Reson Med. 2022; 88(5):2242-2258. PMC: 9420805. DOI: 10.1002/mrm.29382. View

3.
Ferreira P, Banerjee A, Scott A, Khalique Z, Yang G, Rajakulasingam R . Accelerating Cardiac Diffusion Tensor Imaging With a U-Net Based Model: Toward Single Breath-Hold. J Magn Reson Imaging. 2022; 56(6):1691-1704. PMC: 9790699. DOI: 10.1002/jmri.28199. View

4.
Joy G, Kelly C, Webber M, Pierce I, Teh I, McGrath L . Microstructural and Microvascular Phenotype of Sarcomere Mutation Carriers and Overt Hypertrophic Cardiomyopathy. Circulation. 2023; 148(10):808-818. PMC: 10473031. DOI: 10.1161/CIRCULATIONAHA.123.063835. View

5.
Stoeck C, von Deuster C, Genet M, Atkinson D, Kozerke S . Second-order motion-compensated spin echo diffusion tensor imaging of the human heart. Magn Reson Med. 2015; 75(4):1669-76. DOI: 10.1002/mrm.25784. View